Acucela Inc. Appoints Former DuPont Merck Pharmaceuticals Scientist and Ophthalmic Expert, Ghanshyam Patil, Ph.D., as Vice President, Research & Development
3/1/2011 10:22:21 AM
SEATTLE--(BUSINESS WIRE)--Acucela Inc., a clinical-stage specialty pharmaceutical company focused on developing new treatments for blinding eye diseases, today announced that it has appointed Ghanshyam (Shyam) Patil, Ph.D. as Vice President, Research & Development. As a member of Acucela’s growing management team, Dr. Patil will be responsible for leading the direction of the Company’s early pipeline programs in retinopathy of prematurity, Stargardt disease and diabetic retinopathy, as well as evaluating new therapeutic areas for the Company.
comments powered by